Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile.
Paolo
P
Bossi
Laura D
LD
Locati
Lisa
L
Licitra
D016907:Adverse Drug Reaction Reporting Systems; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D005260:Female; D051523:Fibroblast Growth Factor 7 / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009061:Mouth Mucosa / Q000187:drug effects*; D010820:Physicians / Q000592:standards*; D011788:Quality of Life; D013280:Stomatitis / Q000188:drug therapy* / Q000517:prevention & control*
D051523:Fibroblast Growth Factor 7